$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
卡帕塞替尼的副作用与注意事项
2025-10-19 11:44:20
Check Details
卡帕塞替尼的用法用量
2025-10-19 11:44:20
Check Details
卡帕塞替尼的适应症
2025-10-19 11:44:20
Check Details
FDA批准德达博妥单抗治疗HR+/HER2-乳腺癌和EGFR突变NSCLC
2025-10-19 11:44:20
Check Details
德达博妥单抗(Datroway)用法用量:推荐剂量和剂量调整
2025-10-19 11:44:20
Check Details
德达博妥单抗(Datroway)详细说明书
2025-10-19 11:44:20
Check Details
德达博妥单抗(Datroway)中文说明书:适应症、用法用量、不良反应、注意事项
2025-10-19 11:44:20
Check Details
德达博妥单抗一次能囤几盒?多少钱?
2025-10-19 11:44:20
Check Details
德达博妥单抗正品有合适的购买方式吗?
2025-10-19 11:44:20
Check Details
德达博妥单抗的适应症
2025-10-19 11:44:20
Check Details
德达博妥单抗的用药指南
2025-10-19 11:44:20
Check Details
德达博妥单抗的副作用如何缓解
2025-10-19 11:44:20
Check Details
1
2
...
8136
8137
8138
8139
8140
8141
8142
...
10210
10211
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
2
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
3
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
4
Sirolimus (Rapamune) Comprehensive Clinical Guide
5
Lusutrombopag Efficacy, Dosage and Storage Instructions
6
Icotyde (Icotrokinra) Side Effects, Pharmacokinetics and Storage Instructions
7
Cemiplimab (Libtayo) Drug Information
8
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma
9
Urece (Dotinurad): Highly Selective URAT1 Inhibitor for Gout and Hyperuricemia
10
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
11
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
12
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis